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Abstract 33 
 34 
Introduction 35 
Patients who experience an ST-elevation myocardial infarction (STEMI) due to an 36 
occluded coronary artery require prompt treatment. Therapies to open a blocked artery 37 
are called reperfusion therapies (RT) and can include intravenous pharmacological 38 
thrombolysis (TL) or primary percutaneous coronary intervention (pPCI) in a cardiac 39 
catheterisation laboratory (cath lab).  Optimal RT (ORT) with pPCI or TL reduces 40 
morbidity and mortality. In remote areas, a number of geographical and organisational 41 
barriers may influence access to ORT. However, these are not well understood and the 42 
exact proportion of patients who receive ORT and the relationship to time of day and 43 
remoteness from the cardiac cath lab is unknown. 44 
 45 
Aims  46 
To compare the characteristics of ORT delivery in central and remote locations in the 47 
North of Scotland and to identify potential barriers to optimal care with a view to 48 
service redesign. 49 
 50 
Methods 51 
The study was set in the North of Scotland. All patients who attended hospital with a 52 
ST elevation myocardial infarction between March 2014 and April 2015 were identified 53 
from national coding data. A data collection form was developed by the research team 54 
in several iterative stages. Clinical details were collected retrospectively from patients' 55 
discharge letters. Data included treatment location, date of admission, distance to the 56 
cath lab, route of access to health care, left ventricular function and RT received. 57 
Patients were described as remote if > 90 minutes driving time from the cardiac cath 58 
lab and central if ≤ 90 min drive time. For patients who made contact in a pre-hospital 59 
setting ORT was defined as pre-hospital TL or pPCI. For patients who self-presented 60 
to the hospital first, ORT was defined as inhospital TL or pPCI.  Data were described 61 
as mean (SD) as appropriate. Chi-squared and Student’s t-test were used as appropriate. 62 
Each case was reviewed to determine if ORT was received and if not, the reasons for 63 
this were recorded to identify potentially modifiable barriers. Approval from the 64 
Caldecott guardian and Research and Development office were obtained but full ethical 65 
review was not required.  66 
 67 
Results  68 
Of 627 acute myocardial infarction patients initially identified, 131 had a STEMI, the 69 
others were a non-STEMI. From this STEMI cohort, 82 (62%) patients were classed as 70 
central and 49 (38%) were remote. In terms of initial therapy, 26 (20%) received pPCI, 71 
19 (15%) received pre-hospital TLs, 52 (40%) received in-hospital TL, while 33 (25%) 72 
received no initial RT. ORT was received by 53 (65%) central and 20 (41%) remote 73 
patients; Chi-square = 7.05, DF =130, p < 0.01). Several recurring barriers were 74 
identified. 75 
 76 
Conclusion  77 
This study has demonstrated a significant health inequality between the treatment of 78 
STEMI in remote compared to central locations. Potential barriers identified include 79 
staffing availability and training, public awareness and inter-hospital communication. 80 
This suggests that there remain significant opportunities to improve STEMI care for 81 
people living in the North of Scotland. 82 
 83 
Abstract word count 471  84 
Introduction  85 
Myocardial infarction (MI) continues to be a leading cause of death world wide[1]. 86 
According to the British Heart Foundation, in 2013-2014 there were 187,421 hospital 87 
visits in the UK due to MI which translates to someone in the UK having an MI every 88 
three minutes[2]. ST-segment elevation MI (STEMI) represents a high risk of early 89 
death and myocardial damage due to acute occlusion of a coronary artery[3].   90 
 91 
Treatments to open a blocked coronary artery are called reperfusion therapies (RT) and 92 
include pharmacological thrombolysis (TL) that is administered intravenously[4] or 93 
primary percutaneous coronary intervention (pPCI)[5] performed in a cardiac 94 
catheterisation laboratory (cath lab).  Optimal RT (ORT) with pPCI[6] or TL[7] given 95 
timeously (<120 min delay for pPCI and <30 mins for TL) reduces morbidity and 96 
mortality. However, if ORT is not delivered promptly then the risk of death is increased 97 
and left ventricular systolic impairment (LVSD) causing heart failure and an increase 98 
in mortality is more likely[8-10]. 99 
 100 
pPCI is the preferred RT (due to mortality and morbidity benefits)[11,12] although TL 101 
still has a role in the treatment of some patients due to the lack of availability of a cath 102 
lab within the recommended time frame[13]. The European Society of Cardiology 103 
guidelines suggest pPCI should be carried out within 120 minutes[14], if this is not 104 
possible then pre-hospital TL should be given. In practice this will translate to a 105 
maximum transfer time of 90 mins to a cath lab from start of symptoms. Patients who 106 
have a myocardial infarction diagnosed in the pre-hospital setting and are unable to get 107 
to a cath lab within the 90 min from the start of their symptoms should be given TL, 108 
otherwise immediate transfer to a pPCI facility should occur[11]. The delivery of TL 109 
in remote areas could therefore be considered the ORT. 110 
 111 
However, the delivery of ORT in remote areas is not consistent[15] and barriers may 112 
exist including staffing (lack of paramedic crews), education and training (lack of 113 
confidence to deliver prehospital TL) and equipment issues (unable to transmit ECG 114 
for telemetric support)[16]. By identifying modifiable and non-modifiable barriers to 115 
ORT and exploring the factors that might contribute to potential difference in clinical 116 
outcomes between central and remote patients, recommended strategies can be 117 
employed to try to overcome such barriers and mitigate the impact of remoteness in 118 
patient care. However, the exact proportion of patients who receive ORT and the 119 
relationship to time of day and remoteness from the cardiac cath lab is currently 120 
unknown. 121 
 122 
This study aimed to investigate ORT delivery in a remote region in the North of 123 
Scotland in relation to location of STEMI and time of day and to identify potential 124 
barriers to optimal care.  125 
Methods 126 
Participants  127 
Patients who had an STEMI during a 12 month period (March 2014 and April 2015) 128 
were included. Patients were identified from their final diagnosis code on discharge 129 
from hospital or death. Data from patients who died prior to attending hospital were not 130 
included.  131 
 132 
Setting 133 
The study was set in the North of Scotland (NHS Highland). This area represents 41% 134 
of Scotland’s landmass (30,660 km²) with only 4% of the population (232,132)[17]. 135 
There are several hospitals in the area. The regional centre (Raigmore Hospital) is 136 
located in the south east and has a cath lab which operates during office hours (Mon-137 
Fri, 08.30 to 18.00). There are three rural hospitals (‘Broadford’ in Skye, ‘Belford’ in 138 
Fort William, ‘Caithness General’ in Wick) which admit acute cases. Out of hours 139 
access to a cath lab is obtained from three tertiary centres (Aberdeen, Glasgow and 140 
Edinburgh) all > 90 min travel time.  141 
 142 
Study design 143 
This was a retrospective case series review. 144 
 145 
Data collection and handling 146 
The list of potential patients was obtained from the Scottish Morbidity Record (SMR), 147 
which includes date of admission/discharge and location of admission. SMR is an 148 
episode based record relating to all inpatients and day cases discharged from Scottish 149 
hospitals.  The inclusion criterion was any patient diagnosed with STEMI. Exclusion 150 
criteria included diagnosis of a non-STEMI, unknown diagnosis or living outside of the 151 
north of Scotland region. Further clinical details were obtained from the patients’ 152 
discharge letters through Scottish Care Information (SCI) Store (a data repository 153 
which retains patient information at a health board level). Any missing information 154 
from patients discharge letters were obtained from other bespoke clinical reporting 155 
systems (echocardiography and PCI). Self-present patient data were obtained from the 156 
accident and emergency departments. 157 
The primary outcome measure was whether ORT was received or not. Secondary 158 
outcome measures included death and LV function. The following data were obtained 159 
from case note review; age, gender, postcode, time of presentation, date of admission 160 
and discharge, treatment type and location, distance and travel time from cath lab and 161 
LV function. 162 
The travel times via driving a car were obtained using Google Maps[18], although it 163 
should be noted that ambulance drive speed, road conditions and weather will impact 164 
on the actual drive times. Patients were described as remote if >90 minutes and central 165 
if ≤90 driving time from the regional centre. ORT was defined as the best possible RT 166 
for the specific patient at the specific time. Individualising ORT for each patient relied 167 
on several factors; drive time from the nearest cath lab, time and day of presentation, 168 
patient eligibility for PCI/TL and route of access to health care (e.g. self-presenters to 169 
hospital would not be eligible to receive pre-hospital TL). pPCI was considered ORT 170 
for all patients, while pre-hospital TL was considered ORT in all remote patients or 171 
central patients presenting out of ‘cath lab’ working hours (i.e. when pPCI not 172 
available). In-hospital TL was considered ORT only in remote patients who self-173 
presented to hospitals without a cath lab or central patients who self-present out of ‘cath 174 
lab’ hours. Patient who were deemed ineligible for either TL or pPCI were still deemed 175 
to have received ORT for the purposes of this study. (e.g. ORT might represent no RT 176 
if the patient presented late) 177 
For the purposes of this study patient pathways were created after consultation with 178 
several local experts and refined through multiple iterative stages - based on location 179 
of presentation (ambulance or self-presentation), initial management (PHT, in-hospital 180 
TL or PCI), reperfusion outcome and subsequent management. A new pathway was 181 
added where required after reviewing patients’ clinical letters. This led to the 182 
identification of 13 distinct pathways in total.  183 
 184 
The reasons for lack of ORT were determined from the notes review, they were 185 
recorded and described using descriptive statistics. Where the reason for lack of ORT 186 
was not explicitly recorded in the notes then the case was reviewed by a local subject 187 
expert (cardiologist) to determine the cause of lack of ORT. These were then 188 
characterised, quantified and reported using descriptive statistics 189 
 190 
Data analysis and statistics 191 
The data set for continuous data was presented as mean ± standard deviation (SD), 192 
while categorical data were presented as an absolute value, percentage or both. The 193 
Chi-square test was used for comparison of the relationship between remote vs. central 194 
location patients in terms of LV function and whether or not ORT was received. A p-195 
value of <0.05 was considered statistically significant. All tests were performed using 196 
Microsoft Office Excel 2007.  197 
 198 
Ethics 199 
The study was approved by the ethical review panel of the School of Pharmacy and 200 
Life Sciences at Robert Gordon University. Caldecott approval was obtained from NHS 201 
Highland.  202 
Results  203 
During the study period, 627 patients were coded for acute MI, after applying the 204 
inclusion and exclusion criteria 131 STEMI patients were identified (Figure 1). Of the 205 
131 STEMI patients, 83 (63%) were male (age 64 ± 13 years) and 48 (37%) were female 206 
(age 72 ± 11 years). Thirteen distinct clinical pathways were identified (Table 1). Eighty 207 
two (62%) patients were classed as central and 49 (38%) were remote (Table 2). 208 
Place of definitive treatment 209 
The majority of patients, 102 (78%) were treated at some point in their journey at the 210 
regional centre, some patients, 3 (2%) were treated at the rural hospital only while 26 211 
(20%) were admitted out of working hours, did not reperfuse after TL and were 212 
transferred to the tertiary centre bypassing the regional centre. 213 
Reperfusion therapy (RT)  214 
Of the 131 STEMI patients, 26 (20%) received pPCI, 73 (56%) received TL and 32 215 
(24%) received no RT.  Of the 73 patients that received TL, reperfusion occurred in 48 216 
(66%) and among those, 41 (85%) received convalescent PCI. The 25 (19%) that did 217 
not clinically reperfuse were treated with either rescue PCI, 21 (84%) or conservatively 218 
4 (16%) (3 had convalescent PCI and one had no further therapy). Of the 32 patients 219 
that received no initial RT, 24 (75%) received convalescent PCI. (Table 1) 220 
 221 
Optimal Reperfusion Therapy (ORT) 222 
In total, 71 (54%) patients received ORT. Of the 52 patients receiving in-hospital TL 3 223 
(6%) were self-presenters, while an additional 9 (17%) were not eligible for PHT and 224 
thus considered to have received ORT.  Of the 34 patients who received no-RT, 12 225 
(35%) patients were not suitable for TL and 2 (6%) had reperfused by the time of first 226 
medical contact.  227 
 228 
Influence of time of day and remoteness 229 
Central patients were more likely to receive ORT than remote patients (53 (65%) vs. 230 
20 (41%); Chi-square = 7.05, DF =130, p < 0.01). The influence of location and time 231 
of presentation on the initial treatment of remote and central patients are shown in 232 
Figure 2 comparing working hours (a) and out of working hours (b)  233 
 234 
Left ventricular (LV) function 235 
Of the 131 patients, 33 (25%) had a normal LV function, 43 (33%) had a mild LV 236 
dysfunction, 29 (22%) were moderate, and 14 (11%) severe. The majority of patients 237 
who had a normal / mild LV (dys)function after STEMI were from the PHT group n 238 
(79%), while in the pPCI group n (58%) had a normal LV function (Figure 4). There 239 
was no difference between central and remote patients in terms of normal/mild LV 240 
impairment (45 (62%) vs. 31 (53%); p=0.35) although the study was under powered to 241 
show differences. 242 
 243 
Barriers to ORT 244 
Each of the 60 cases where ORT was not delivered was discussed with a cardiologist 245 
and the reason for ‘no ORT’ identified. These included include 38 (63%) cases where 246 
PHT was not given (due to lack of trained staff), 4 (7%) cases where poor inter-hospital 247 
communication led to no RT and 9 (15%) cases where the patients presented late. In 7 248 
(12%) cases there was either a non-diagnostic ECG or atypical symptoms. 249 
  250 
Discussion  251 
This is the first paper to report differences between remote and central patients in an 252 
area which employs a hybrid reperfusion approach to STEMI care (both pPCI and TL 253 
used). The results show a clear variation in care between remote and central patients. 254 
What was not expected was the lower proportion of patients who received no-RT during 255 
office hours at the regional centre compared with all other periods. While there was no 256 
obvious difference in clinical outcomes measured by significant LV dysfunction 257 
between the remote and central groups the numbers are too small to be able to draw 258 
any definitive conclusions about any potential harm. 259 
 260 
Results from this study are generally comparable with the Euro Heart Survey Acute 261 
Coronary Syndromes (EHS-ACS)[19] and the Global Registry of Acute Coronary 262 
Events (GRACE)[20]. In both studies, the majority of patients were male with a mean 263 
age similar to that in this present study. Interestingly, more central patients in our study 264 
received pPCI than in the EHS-ACS study, although these data are older and according 265 
to a more recent national audit of PCI, 91% of patients located within 90 minutes of a 266 
PCI centre were treated with pPCI[21]. This percentage is significantly higher than our 267 
central pPCI patients which can be explained by in-hours only availability of the ‘cath 268 
lab’. 269 
 270 
pPCI is the gold standard treatment for STEMI and has been shown to have mortality 271 
advantages over thrombolysis in several trials[6,22]. However, the majority of trials 272 
showing superiority of pPCI have compared pPCI with hospital not pre-hospital TL 273 
although equivalence has been shown more recently with pre-hospital TL, presumably 274 
the earlier the TL is given, the more likely it is to be effective. In our study, the 275 
proportion of STEMI patients who received pPCI was heavily influenced by the cath 276 
lab opening hours (limited to office hours) therefore the majority of STEMI patients 277 
did not receive pPCI. There was obviously a major difference between remote and 278 
central patients in this regard with no remote patients receiving pPCI. 279 
 280 
Thrombolysis as a treatment for STEMI was established in the 1980s after the ISIS 281 
trials using streptokinase[23] and until the emergence of pPCI was the mainstay of 282 
reperfusion treatment. It is well recognised that TL is most effective when given early 283 
(e.g. within 1 hr of artery occlusion). In the real world setting this is rarely achievable 284 
due to several factors including delayed call for help and sometimes limited availability 285 
of pre-hospital staff to deliver TL. This is a particular issue in remote areas in the UK 286 
where there is a relative lack of trained paramedics and thus remote patients are 287 
potentially at a double disadvantage being too far from a cath lab and served by 288 
ambulance staff with a lower chance of having paramedic crew. Our data reflect this 289 
reality with fewer patients in remote areas receiving PHT. 290 
  291 
Despite the differences noted in the use of pPCI and TL there were no obvious 292 
difference in outcomes and indeed LV function was, if anything, more often normal in 293 
the TL subgroup, although the numbers were small making firm conclusions more 294 
difficult. There were only a small number of deaths in our cohort and it is therefore 295 
difficult to draw conclusions about mortality. Prior studies have reported higher 296 
mortality in remote MI patients[24]. The reasons for this are unknown but likely to be 297 
multifactorial. Due to the small numbers in many studies of remote and rural patients 298 
involved it is difficult to draw firm conclusions although one study suggested the 299 
increased mortality rates for remote acute MI patients did not appear to be related to 300 
lower quality of care[25].  A simple explanation to the higher mortality rates could be 301 
due to an older population that resides in remote areas, while studies suggest that 302 
variation in STEMI treatment could be attributed to the fact that patients with advanced 303 
age and co-morbidities, are less likely to be treated with RT despite the data confirming 304 
that these patients would benefit significantly from such treatment[26,27]. However, 305 
we did not include pre-hospital deaths in our cohort and therefore are unsure what the 306 
over all death rate from acute MI is. 307 
 308 
This current study also quantified the barriers to ORT. Four barriers were identified 309 
including: poor communication between hospitals; late presentation; non-diagnostic 310 
ECGs or atypical symptoms. However, the most frequent barrier encountered was the 311 
lack of PHT administered by paramedics most commonly due to a lack of a paramedic 312 
on the crews. Paramedics are experts in pre-hospital care and play a vital role in PHT 313 
administration. A study to test paramedic’s ability to identify patients eligible for 314 
thrombolytic therapy, and thus reducing call-to-needle time, concluded that a mean 315 
potential saving time of 41 minutes is achieved[28]. Service providers need to take this 316 
into consideration. In this study's sample, the majority of non-ORT patients were 317 
eligible for PHT if trained paramedics were in place – this demonstrates a health 318 
inequality in remote areas with regard to STEMI patients getting access to ORT. Our 319 
area therefore needs to ensure that all PHT responders are trained to provide appropriate 320 
treatment to individual patients and to ensure that all ambulances are staffed with 321 
paramedics. This is not an insurmountable issue and with better staff training pre-322 
hospital thrombolysis (PHT) administered by trained paramedics or dual response 323 
primary care physician / general practitioner (GP) could likely be increased. Training 324 
primary care physicians in remote areas showed significant reduction in delay from call 325 
to needle time, by an average of 17 minutes.  Diagnosis made by the GP was reliable 326 
and safe with 95% of the initial STEMI diagnosis being confirmed[29].  In our area we 327 
provide a telemetric and decision support service from the coronary care unit but clearly 328 
our result show that more work is needed to increase us of PHT in remote patients. 329 
 330 
Delayed call for help is a well identified barrier to ORT which was outside the scope 331 
of this study due to poor and inconsistent documentation of this parameter. The GRACE 332 
registry of 11,543 patients with acute coronary syndrome indicated that the median time 333 
between symptoms onset and call for help was 139 minutes, suggesting even with the 334 
most advanced systems of care some barriers are difficult to overcome[20].  The reason 335 
could be that published guidelines attempting to standardise STEMI care are not 336 
individualized for each facility, thus adherence to STEMI guidelines might not be 337 
feasible in remote sites. According to the study of Bata et al., ORT can be achieved 338 
through rapid pre-hospital diagnosis and improving systems of care[30]. However, little 339 
effort has been made in identifying the causes of such challenges in remote areas and 340 
this is an area for future research. 341 
 342 
Although transfer distance has a major impact on ischaemic time[31], and PHT is the 343 
optimal therapy if door-to-balloon ≥ 90 min[11,12], PHT was not utilised for most 344 
remote patients, and a higher use of PHT was seen in central patients with considerable 345 
variations between working and out of working hours. Holmes et al. reported that a 346 
successful regional care model can reduce the disparity of care between off-hours and 347 
working hours for patients with STEMI[32]. Therefore establishing a local policy to 348 
provide consistent quality of care might be key factor in providing ORT. 349 
Limitations 350 
This study has limitations, firstly, the retrospective design depends on the quality of 351 
routinely collected data and certain parameters such as time from symptom onset to call 352 
for help were not consistently available. Nevertheless, we were able to include all 353 
STEMI and due to the national radiology reporting system and electronic patient 354 
discharge letters were able to report clinical data for all patients. Secondly, the use of 355 
Google maps[18] to measure travel time via a car is not a validated tool for an 356 
ambulance and paramedic crews might be quicker due to their training, road use and 357 
advanced driving skills. Furthermore, volume of traffic at different times of the day or 358 
year will affect travel times. Notwithstanding this limitation, Google maps provided a 359 
systematic approach. A further limitation was that while we had data on hospital of first 360 
admission and home address we could not always confirm that myocardial infarction 361 
had occurred at the home address and it is possible a small number of patients had their 362 
event elsewhere although if there had been a large different in location this would have 363 
been obvious from a disconnect between home location and local hospital which was 364 
not found. Finally, the study sample included patients diagnosed with STEMI and 365 
admitted to a hospital. Any patient, who did not survive a STEMI before being admitted 366 
was therefore not included. This may affect interpretation of the data and conceal 367 
mortality differences but addressing this limitation was outside the scope of the study.  368 
 369 
Conclusion 370 
This study has shown that ORT delivery is suboptimal in the whole study region; 371 
furthermore, a clear difference in access to ORT exists between central and remote 372 
patients demonstrating a health inequality between patients living in central and 373 
remote areas. Disappointingly, remote patients, while geographically unable to reach 374 
an available ‘cath lab’ in time, were also less likely to receive PHT and therefore 375 
potentially exposed to higher risk. Reassuringly during working hours, the vast 376 
majority of central patients received pPCI which reflects ORT, but more needs to be 377 
done to improve PHT use out of hours. This study confirms that communication and 378 
pathways could be improved (e.g. bypassing non-PCI capable hospitals) but the major 379 
barrier identified to the delivery of ORT was the lack of trained paramedics which 380 
should be addressed with some urgency.   381 
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Table 1  Reperfusion therapy pathways (n=131) 542 
Prehospital thrombolysis (PHT), primary Percutaneous Coronary Intervention (pPCI) 543 
 544 
 545 
 546 
 547 
  548 
Pathway Thrombolysis 
location 
Outcome from 
thrombolysis 
PCI type Patients 
n (%) 
1 None N/A pPCI 26 (20) 
2 PHT Reperfused Convalescent 8 (6) 
3 PHT Reperfused None 3(2) 
4 PHT Not Reperfused Rescue 6 (5) 
5 PHT Not Reperfused Convalescent 2 (2) 
6 PHT Not Reperfused None 0 (0) 
7 Hospital Reperfused Convalescent 35 (27) 
8 Hospital Reperfused None 3 (2) 
9 Hospital Not Reperfused Rescue 12(9) 
10 Hospital Not Reperfused Convalescent 1 (1) 
11 Hospital Not Reperfused None 1 (1) 
12 None N/A Convalescent 26 (20) 
13 None N/A None 8 (6) 
Table 2  Patient distance from regional centre based on drive time 549 
 550 
Driving times (mins) Patients n (%) 
≤ 30   49 (37.0)  
30-60  25 (19.0)  
60-90 8 (6.0) 
90-120 10 (8.0) 
≥ 120 39 (30.0)  
  551 
Figure 1 CONSORT flow diagram  552 
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Figure 2a Initial reperfusion therapy when cath lab at regional centre closed 553 
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Figure 2b Initial reperfusion therapy when cath lab at regional centre open  570 
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Figure 3 Percentage of patients with normal or mildly impaired LV function post 571 
myocardial infarction by initial reperfusion therapy. (Primary percutaneous 572 
coronary intervention (PPCI), prehospital thrombolysis (PHT). 573 
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